[1]
2015. Retraction: Monotherapy with meropenem versus combination therapy of ceftazidime plus amikacin for empirical treatment of cancer patients with Febrile Neutropenic (FN): systematic review and meta-analysis. European Journal of Oncology and Environmental Health. 20, 1 (Sep. 2015), 5–16.